Investor's Champion
How to make your money go further

Whopping contract | FDA approval | Another offer

02/11/2023 · Cerillion (CER)  · Creo Medical (CREO)  · Equals Group PLC (EQLS)  · Oxford Metrics (OMG)  · Premier Miton Group (PMI)  · Sopheon  
AIM AIM Inheritance Tax potential UK

Our free update here includes news of yet another significant contract win for a high-performing AIM software company. Elsewhere, two companies are starting to put their significant cash piles to hopefully better use with acquisitions, while yet another AIM company is under offer, this time for a big premium. Read on here for this and other news.

Cerillion secures another whopper Cerillion (AIM:CER), the creator of software for billing, charging and customer relationship management, has announced another significant contract win to add further support to its lofty valuation. Cerillion has signed a major new contract, worth an initial €12.4m, with a Tier-1 telecommunications provider, based in Europe. Cerillion will be supplying and implementing the core elements of its flagship solution, including billing, charging, fulfilment and product catalogue, on a SaaS basis, for an initial 5-year term. Over time, Cerillion believes that this new relationship has the potential to develop further. The Group’s single product approach confers all…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login